STRATA Skin Sciences Inc (NASDAQ:SSKN) was the recipient of a large drop in short interest in September. As of September 28th, there was short interest totalling 888,178 shares, a drop of 34.1% from the September 14th total of 1,348,643 shares. Currently, 5.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 356,993 shares, the days-to-cover ratio is currently 2.5 days.

Several institutional investors have recently bought and sold shares of the company. Macquarie Group Ltd. raised its position in STRATA Skin Sciences by 89.7% in the 2nd quarter. Macquarie Group Ltd. now owns 134,033 shares of the medical device company’s stock worth $275,000 after purchasing an additional 63,393 shares during the period. Renaissance Technologies LLC raised its position in STRATA Skin Sciences by 164.6% in the 2nd quarter. Renaissance Technologies LLC now owns 293,499 shares of the medical device company’s stock worth $602,000 after purchasing an additional 182,579 shares during the period. Menora Mivtachim Holdings LTD. purchased a new position in STRATA Skin Sciences in the 2nd quarter worth $1,138,000. Finally, Nantahala Capital Management LLC purchased a new position in STRATA Skin Sciences in the 2nd quarter worth $4,261,000. Hedge funds and other institutional investors own 27.41% of the company’s stock.

Several analysts have recently weighed in on SSKN shares. ValuEngine upgraded shares of STRATA Skin Sciences from a “hold” rating to a “buy” rating in a research report on Thursday, July 5th. Zacks Investment Research cut shares of STRATA Skin Sciences from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 1st. HC Wainwright set a $3.00 price objective on shares of STRATA Skin Sciences and gave the company a “buy” rating in a research report on Tuesday, August 14th. Finally, Dawson James started coverage on shares of STRATA Skin Sciences in a research report on Tuesday, September 4th. They set a “buy” rating on the stock.

STRATA Skin Sciences stock opened at $3.17 on Friday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 4.20 and a current ratio of 4.77. The firm has a market cap of $106.00 million, a PE ratio of 1.61 and a beta of 0.57. STRATA Skin Sciences has a fifty-two week low of $1.06 and a fifty-two week high of $3.88.

STRATA Skin Sciences (NASDAQ:SSKN) last posted its quarterly earnings data on Monday, August 13th. The medical device company reported ($0.02) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.03) by $0.01. The firm had revenue of $7.53 million for the quarter, compared to analysts’ expectations of $6.84 million. STRATA Skin Sciences had a negative net margin of 63.07% and a negative return on equity of 27.01%. As a group, equities analysts forecast that STRATA Skin Sciences will post -0.2 earnings per share for the current year.

STRATA Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, focuses on the therapeutic and aesthetic dermatology market. The company operates through three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment, and Dermatology Imaging. Its products include XTRAC laser and VTRAC excimer lamp systems used for the treatment of psoriasis, vitiligo, and other skin conditions; the STRATAPEN MicroSystems, a micropigmentation device; and Nordlys, a multi-technology aesthetic laser device for treating vascular and pigmented lesions.

See Also: How are the companies in the S&P 500 selected?

Receive News & Ratings for STRATA Skin Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STRATA Skin Sciences and related companies with MarketBeat.com's FREE daily email newsletter.